Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the emerging role of the intestine as a significant source of lipids and a target for controlling clinical dyslipidemia.
Spencer D Proctor†, Donna F Vine, Kathleen M Botham, John CL Mamo & Manuel Castro Cabezas †Author for correspondence University of Alberta, Alberta Institute for Human Nutrition, Principal Member Alberta Diabetes Institute, Associate Member Molecular Cell Biology of Lipids, C/O 4–10, Agriculture/ Forestry Centre, Edmonton, Alberta, T6G 2P5, Canada Tel.: +1 780 492 4672 (Office); +1 780 492 6358 (Lab); Fax: +1 780 492 9270; spencer.proctor@ualberta.ca ‘The intestine is now viewed as a significant source of dietary and endogenous lipids and has evolved into a recent target for the control of clinical dyslipidemia.’
No takes yet. Share an insight, caveat, or question.
Proctor et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: